Simone Leyden AM is a senior director of Global Patient Advocacy and Government Affairs at Telix Pharmaceuticals Limited and a co-founder of NeuroEndocrine Cancer Australia. With a background in business management focused on marketing from Monash University, Simone has extensive experience in stakeholder engagement and promoting research in the less common cancer space. Simone served as CEO of NeuroEndocrine Cancer Australia from 2011 to 2022 and held the position of President at the International Neuroendocrine Cancer Alliance from 2018 to 2020. In addition to these roles, Simone has contributed to various professional groups and held significant positions in the advertising and medical fields.
Location
Melbourne, Australia
Links
This person is not in any teams
This person is not in any offices